Patents by Inventor Rossella Musa

Rossella Musa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
    Publication number: 20230364015
    Abstract: Carrier particles for dry powder formulations for inhalation having reduced electrostatic charges are prepared.
    Type: Application
    Filed: July 17, 2023
    Publication date: November 16, 2023
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Daniela COCCONI, Rossella Musa
  • Tobramycin magnesium stearate microparticles for inhalation, compositions thereof, and methods of making and using the same
    Patent number: 10857169
    Abstract: Powder formulations for inhalation which comprise microparticles containing an antibiotic and magnesium stearate are useful for the treatment of bacterial infections associated with certain pulmonary diseases.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: December 8, 2020
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: David Morton, Qi Zhou, Rossella Musa
  • Method of making particles for use in a pharmaceutical composition
    Patent number: 10561613
    Abstract: A method for making composite excipient particles for use in a pharmaceutical composition comprises a milling step in which particles of an excipient material are milled in the presence of an additive material. The product particles are of small size and the milling requires relatively low input of time and energy. The composite particles are suitable for use in inhalable pharmaceutical compositions.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: February 18, 2020
    Assignee: VECTURA LIMITED
    Inventors: John Nicholas Staniforth, David Alexander Vodden Morton, Rossella Musa
  • PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
    Publication number: 20190216731
    Abstract: Carrier particles for dry powder formulations for inhalation having reduced electrostatic charges are prepared.
    Type: Application
    Filed: March 21, 2019
    Publication date: July 18, 2019
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Daniela Cocconi, Rossella Musa
  • Method Of Making Particles For Use In A Pharmaceutical Composition
    Publication number: 20180055772
    Abstract: A method for making composite excipient particles for use in a pharmaceutical composition comprises a milling step in which particles of an excipient material are milled in the presence of an additive material. The product particles are of small size and the milling requires relatively low input of time and energy. The composite particles are suitable for use in inhalable pharmaceutical compositions.
    Type: Application
    Filed: October 31, 2017
    Publication date: March 1, 2018
    Inventors: John Nicholas Staniforth, David Alexander Vodden Morton, Rossella Musa
  • Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 9808422
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: November 7, 2017
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Irene Pasquali, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Pharmaceutical formulations for dry powder inhalers
    Patent number: 9566239
    Abstract: A powder for use in a dry powder inhaler comprises: i) a fraction of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse particles; and iii) at least one active ingredient. The powder is suitable for efficacious delivery of active ingredients into the low respiratory tract of patients suffering from pulmonary diseases such as asthma. In particular, the invention provides a formulation to be administered as dry powder for inhalation which is freely flowable, can be produced in a simple way, is physically and chemically stable and capable of delivering accurate doses and/or high fine particle fraction of low strength active ingredients by using a high- or medium resistance device.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: February 14, 2017
    Assignee: VECTURA LIMITED
    Inventors: John Nicholas Staniforth, David Alexander Vodden Morton, Rajbir Gill, Gaetano Brambilla, Rossella Musa, Lorenzo Ferrarini
  • PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATION
    Publication number: 20160354314
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Application
    Filed: August 19, 2016
    Publication date: December 8, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Rossella MUSA, Daniela COCCONI, Alain CHAMAYOU, Laurence GALET
  • Process for preparing carrier particles for dry powders for inhalation
    Patent number: 9445999
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: September 20, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Alain Chamayou, Laurence Galet
  • DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20160263027
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Method Of Making Particles For Use In A Pharmaceutical Composition
    Publication number: 20160243039
    Abstract: A method for making composite excipient particles for use in a pharmaceutical composition comprises a milling step in which particles of an excipient material are milled in the presence of an additive material. The product particles are of small size and the milling requires relatively low input of time and energy. The composite particles are suitable for use in inhalable pharmaceutical compositions.
    Type: Application
    Filed: May 2, 2016
    Publication date: August 25, 2016
    Inventors: JOHN NICHOLAS STANIFORTH, DAVID ALEXANDER VODDEN MORTON, ROSSELLA MUSA
  • Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 9402825
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: August 2, 2016
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Irene Pasquali, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Method of making particles for use in a pharmaceutical composition
    Patent number: 9351928
    Abstract: A method for making composite excipient particles for use in a pharmaceutical composition comprises a milling step in which particles of an excipient material are milled in the presence of an additive material. The product particles are of small size and the milling requires relatively low input of time and energy. The composite particles are suitable for use in inhalable pharmaceutical compositions.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: May 31, 2016
    Assignee: VECTURA LIMITED
    Inventors: John Nicholas Staniforth, David Alexander Vodden Morton, Rossella Musa
  • PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATION
    Publication number: 20150202159
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Application
    Filed: January 28, 2015
    Publication date: July 23, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Rossella MUSA, Daniela COCCONI, Alain CHAMAYOU, Laurence GALET
  • Process for preparing carrier particles for dry powders for inhalation
    Patent number: 8974831
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: March 10, 2015
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Alain Chamayou, Laurence Galet
  • PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS
    Publication number: 20150050350
    Abstract: A powder for use in a dry powder inhaler comprises: i) a fraction of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse particles; and iii) at least one active ingredient. The powder is suitable for efficacious delivery of active ingredients into the low respiratory tract of patients suffering from pulmonary diseases such as asthma. In particular, the invention provides a formulation to be administered as dry powder for inhalation which is freely flowable, can be produced in a simple way, is physically and chemically stable and capable of delivering accurate doses and/or high fine particle fraction of low strength active ingredients by using a high- or medium resistance device.
    Type: Application
    Filed: September 22, 2014
    Publication date: February 19, 2015
    Inventors: John Nicholas Staniforth, David Alexander Vodden Morton, Rajbir Gill, Gaetano Brambilla, Rossella Musa, Lorenzo Ferrarini
  • DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20150017248
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Application
    Filed: July 10, 2014
    Publication date: January 15, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Pharmaceutical formulations for dry powder inhalers
    Patent number: 8871274
    Abstract: A powder for use in a dry powder inhaler comprises: i) a fraction of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse particles; and iii) at least one active ingredient. The powder is suitable for efficacious delivery of active ingredients into the low respiratory tract of patients suffering from pulmonary diseases such as asthma. In particular, the invention provides a formulation to be administered as dry powder for inhalation which is freely flowable, can be produced in a simple way, is physically and chemically stable and capable of delivering accurate doses and/or high fine particle fraction of low strength active ingredients by using a high- or medium resistance device.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: October 28, 2014
    Assignee: Vectura Limited
    Inventors: John Nicholas Staniforth, David Alexander Vodden Morton, Rajbir Gill, Gaetano Brambilla, Rossella Musa, Lorenzo Ferrarini
  • Micronized particles of low-dosage strength active agents for powder formulations for inhalation
    Patent number: 8512753
    Abstract: Micronized particles of a low-dosage strength active ingredient, to be used in dry powder formulations for inhalation, with particular properties can easily and homogenously disperse in a dry powder formulation to be administered by means of a dry powder inhaler device.
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: August 20, 2013
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Silvia Catinella
  • FORMULATIONS FOR USE IN INHALER DEVICES
    Publication number: 20120308613
    Abstract: A formulation for an inhaler device comprises carrier particles having a diameter of at least 50 ?m and a mass median diameter of at least 175 ?m; active particles; and additive material to which is able to promote release of the active particles from the carrier particles on actuation of the inhaler device. The formulation has excellent flowability even at relatively high fine particle contents.
    Type: Application
    Filed: April 25, 2012
    Publication date: December 6, 2012
    Applicant: VECTURA LIMITED
    Inventors: John Nicholas Staniforth, David Alexander Vodden Morton, Rajbir Gill, Gaetano Brambilla, Rossella Musa, Lorenzno Ferrarini